3-n-methylspiperone has been researched along with Eye Cancer, Retinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, AC; Monsma, FJ; Sibley, DR | 1 |
| Brassard, DL; Monsma, FJ; Sibley, DR | 1 |
2 other study(ies) available for 3-n-methylspiperone and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Expression of functional D2 dopamine receptors following differentiation of Y-79 human retinoblastoma cells.
Topics: Adenylyl Cyclase Inhibitors; Binding, Competitive; Cell Membrane; Colforsin; Dopamine; Dopamine Agents; Dopamine Antagonists; Eye Neoplasms; Guanylyl Imidodiphosphate; Humans; Receptors, Dopamine; Receptors, Dopamine D2; Retinoblastoma; Spiperone; Tumor Cells, Cultured | 1990 |
Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
Topics: Animals; Benzazepines; Binding, Competitive; Cell Line; Dopamine Antagonists; Humans; Mice; Neuroblastoma; Receptors, Dopamine; Retinoblastoma; Spiperone; Tumor Cells, Cultured | 1989 |